Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment.
Saved in:
| Title: | Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment. |
|---|---|
| Authors: | Carreira B; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: a.carreira@ff.ulisboa.pt., Acúrcio RC; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: ritaacurcio@ff.ulisboa.pt., Matos AI; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: aimatos@ff.ulisboa.pt., Moura LIF; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: lmoura@ff.ulisboa.pt., Afonso MB; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: mbafonso@ff.ulisboa.pt., Viana AS; Centro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisbon, Portugal. Electronic address: anaviana@fc.ul.pt., Santos FMF; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: fmfsantos@ff.ulisboa.pt., Gois PMP; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: pedrogois@ff.ulisboa.pt., Rodrigues CMP; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: cmprodrigues@ff.ulisboa.pt., Guedes RC; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: rguedes@ff.ulisboa.pt., Satchi-Fainaro R; Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel. Electronic address: ronitsf@tauex.tau.ac.il., Florindo HF; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: hflorindo@ff.ulisboa.pt. |
| Source: | Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Nov 10; Vol. 387, pp. 114178. Date of Electronic Publication: 2025 Aug 29. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40886775 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Carreira+B%22">Carreira B</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: a.carreira@ff.ulisboa.pt.<br /><searchLink fieldCode="AU" term="%22Acúrcio+RC%22">Acúrcio RC</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: ritaacurcio@ff.ulisboa.pt.<br /><searchLink fieldCode="AU" term="%22Matos+AI%22">Matos AI</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: aimatos@ff.ulisboa.pt.<br /><searchLink fieldCode="AU" term="%22Moura+LIF%22">Moura LIF</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: lmoura@ff.ulisboa.pt.<br /><searchLink fieldCode="AU" term="%22Afonso+MB%22">Afonso MB</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: mbafonso@ff.ulisboa.pt.<br /><searchLink fieldCode="AU" term="%22Viana+AS%22">Viana AS</searchLink>; Centro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Campo Grande, 1749-016 Lisbon, Portugal. Electronic address: anaviana@fc.ul.pt.<br /><searchLink fieldCode="AU" term="%22Santos+FMF%22">Santos FMF</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: fmfsantos@ff.ulisboa.pt.<br /><searchLink fieldCode="AU" term="%22Gois+PMP%22">Gois PMP</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: pedrogois@ff.ulisboa.pt.<br /><searchLink fieldCode="AU" term="%22Rodrigues+CMP%22">Rodrigues CMP</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: cmprodrigues@ff.ulisboa.pt.<br /><searchLink fieldCode="AU" term="%22Guedes+RC%22">Guedes RC</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: rguedes@ff.ulisboa.pt.<br /><searchLink fieldCode="AU" term="%22Satchi-Fainaro+R%22">Satchi-Fainaro R</searchLink>; Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel; Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel. Electronic address: ronitsf@tauex.tau.ac.il.<br /><searchLink fieldCode="AU" term="%22Florindo+HF%22">Florindo HF</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisbon, Portugal. Electronic address: hflorindo@ff.ulisboa.pt. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228607908%22">Journal of controlled release : official journal of the Controlled Release Society</searchLink> [J Control Release] 2025 Nov 10; Vol. 387, pp. 114178. <i>Date of Electronic Publication: </i>2025 Aug 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publishers%22">Elsevier Science Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8607908 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-4995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201683659%22">01683659 </searchLink><i>NLM ISO Abbreviation: </i>J Control Release <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40886775 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jconrel.2025.114178 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 114178 Titles: – TitleFull: Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Carreira B – PersonEntity: Name: NameFull: Acúrcio RC – PersonEntity: Name: NameFull: Matos AI – PersonEntity: Name: NameFull: Moura LIF – PersonEntity: Name: NameFull: Afonso MB – PersonEntity: Name: NameFull: Viana AS – PersonEntity: Name: NameFull: Santos FMF – PersonEntity: Name: NameFull: Gois PMP – PersonEntity: Name: NameFull: Rodrigues CMP – PersonEntity: Name: NameFull: Guedes RC – PersonEntity: Name: NameFull: Satchi-Fainaro R – PersonEntity: Name: NameFull: Florindo HF IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 11 Text: 2025 Nov 10 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1873-4995 Numbering: – Type: volume Value: 387 Titles: – TitleFull: Journal of controlled release : official journal of the Controlled Release Society Type: main |
| ResultId | 1 |